Completed PHASE1/PHASE2 INTERVENTIONAL NCT00002510

Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

HIGH-DOSE CHEMORADIOTHERAPY FOLLOWED BY RESCUE WITH MOBILIZED AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH LOW-GRADE, TRANSFORMED, OR FOLLICULAR LARGE CELL NON-HODGKIN'S LYMPHOMA

Sponsor: Fox Chase Cancer Center

Conditions Lymphoma

Interventions cyclophosphamide etoposide filgrastim mesna peripheral blood stem cell transplantation radiation therapy

Updated 5 times since 2017 Last updated: Sep 30, 2010 Started: Apr 30, 1992 Primary completion: Jun 30, 2001 Completion: Jun 30, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002510, this PHASE1/PHASE2 trial focuses on Lymphoma and remains completed. Sponsored by Fox Chase Cancer Center, it has been updated 5 times since 1992, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Apr 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fox Chase Cancer Center
Temple University

Data source: Temple University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States